aplastic anemia | Page 36 | Aplastic Anemia & MDS International Foundation

aplastic anemia

Blood stream infection after stem cell transplantation in children with idiopathic aplastic anemia

Author(s): 
Kobayashi R, Yabe H, Kikuchi A, Kudo K, Yoshida N, Watanabe K, Muramatsu H, Takahashi Y, Inoue M, Koh K, Inagaki J, Okamoto Y, Sakamaki H, Kawa K, Kato K, Suzuki R, Kojima S
Primary Author: 
Kobayashi R
Journal Title: 
Biol Blood Marrow Transplant
Original Publication Date: 
Apr 2014

Blood stream infection (BSI) is the most common infectious complication of hematopoietic stem cell transplantation (HSCT) and can cause substantial morbidity and mortality. Identification of risk factors for BSI might be helpful in efforts to reduce transplant-related death. This study analyzed the incidence of BSI and risk factors for BSI after

Bone Marrow Diseases: 

Bone marrow mesenchymal stem cells from aplastic anemia patients preserve functional and immune properties and do not contribute to the pathogenesis of the disease

Author(s): 
Bueno C, Roldan M, Anguita E, Romero-Moya D, Martín-Antonio B, Rosu-Myles M, Del Cañizo C, Campos F, García R, Gómez-Casares M, Fuster JL, Jurado M, Delgado M, Menendez P
Primary Author: 
Bueno C
Journal Title: 
Haematologica
Original Publication Date: 
Apr 2014

Bone Marrow Diseases: 

Comparison of Rabbit Antithymocyte Globulin (R-ATG) and Jurkat Cell-Reactive Anti-T Lymphocyte Globulin (ATG-F) as a First-line Treatment for Children with Aplastic Anemia

Author(s): 
Xie X, Shi W, Zhou X, Shao Y, Qiao X
Primary Author: 
Xie X
Journal Title: 
Exp Hematol
Original Publication Date: 
Feb 2014

OBJECTIVE:

To investigate the effects of rabbit anti-human thymocyte globulin (R-ATG) and Jurkat cell-reactive anti-T lymphocyte

Bone Marrow Diseases: 

Reduced intensity conditioning, combined transplantation of haploidentical hematopoietic stem cells and mesenchymal stem cells in patients with severe aplastic anemia

Author(s): 
Li XH, Gao CJ, Da WM, Cao YB, Wang ZH, Xu LX, Wu YM, Liu B, Liu ZY, Yan B, Li SW, Yang XL, Wu XX, Han ZC
Primary Author: 
Li XH
Journal Title: 
PLoS One
Original Publication Date: 
Mar 2014

We examined if transplantation of combined haploidentical hematopoietic

Bone Marrow Diseases: 

Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia

Author(s): 
McGuinn C, Geyer MB, Jin Z, Garvin JH, Satwani P, Bradley MB, Bhatia M, George D, Duffy D, Morris E, van de Ven C, Schwartz J, Baxter-Lowe LA, Cairo MS
Primary Author: 
McGuinn C
Journal Title: 
Pediatr Blood Cancer
Original Publication Date: 
Feb 2014

BACKGROUND:

Bone Marrow Diseases: